Sleep apnea

What it is

Sleep apnoea is the repeated blocking of breathing during sleep, most often from a collapsing airway in people who are overweight, causing fragmented sleep, daytime tiredness and higher cardiovascular risk. It is in the news because weight-loss drugs now treat it: tirzepatide is approved for sleep apnoea in obesity, and oral GLP-1 pills have shown similar results in trials. CPAP machines remain the standard treatment and work well when used; many people with the condition are undiagnosed.

This week · Eli Lilly's GLP-1 pill Foundayo cut breathing interruptions by up to 44 percent on average at 52 weeks in two trials reported at the American Heart Association meeting.

Written by the Alivewire editors from the coverage below, 1d ago. Not medical advice; how the ratings work.